Could carbon monoxide be a medicine? new trial for sickle cell
NCT ID NCT06144749
First seen Jan 09, 2026 · Last updated May 14, 2026 · Updated 18 times
Summary
This early-phase trial tests an oral liquid containing carbon monoxide (HBI-002) in 9 people with sickle cell disease aged 14-55. The goal is to see if it is safe and how the body processes it when taken daily for 14 days. This is not a cure but aims to help manage the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA, SICKLE CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cevaxin - The Panama Clinic
RECRUITINGPanama City, Panama
-
Hospital Pacífica Salud
RECRUITINGPanama City, Panama
Conditions
Explore the condition pages connected to this study.